Shipping
Same-day shipping on USA orders placed before 2PM EST.
View Shipping Policy →
99%+ Purity Guaranteed
Research Use Only
Secure Checkout
BPC-157 + TB-500 (Blend)
SKU: BL-TBBPC-10M
Same Trusted Formula. Fresh New Look.During our packaging transition, you may receive products with either our previous or updated label. Rest assured, the formulation, purity and quality remain exactly the same as per our standards.
Accepted Payment MethodsYour data is protected with 256-bit encryption.
Returns
30-day hassle-free returns on unopened products.
View Returns Policy →Lab Tested
Every batch is tested for purity, potency and quality.
View Lab Results →Support
Have a question? Our team is here to help you.
Contact Us →BPC-157 + TB-500 Blend
This vial contains a pre-formulated blend of BPC-157 and TB-500 , two synthetic peptides with distinct molecular mechanisms and signaling characteristics. BPC-157 has been investigated for interactions with VEGFR2-, FAK-, and eNOS-associated signaling pathways together with regulatory processes involving extracellular protein networks. TB-500, a synthetic analogue of Thymosin Beta-4, interacts with G-actin through the conserved LKKTET motif, influencing actin-binding dynamics, cytoskeletal organization, and actin-associated signaling systems. The co-formulated preparation provides a convenient research tool for investigating multiple peptide-mediated signaling pathways, actin-regulatory mechanisms, and pathway interactions within a single experimental framework.
.
- High Purity — 99%+ Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
All SwissChems products are independently third-party tested at a USA-based HPLC-licensed laboratory prior to distribution. Certificates of Analysis (COA) are published on the Independent Test Results page and available at product level. If any independently conducted HPLC test returns a negative result, SwissChems will refund: (1) the cost of the HPLC test, and (2) the full order amount including shipping.
| Chemical Formula | C62H98N16O22 / C212H350N56O78S |
|---|---|
| Synonyms | BPC-157 + Thymosin Beta-4 Blend, BPC/TB Blend |
| Molar Mass | 1,419.5 / 4,963.4 g/mol |
| CAS Number | 137525-51-0 | 77591-33-4 |
| PubChem CID | 9941957 / 16132341 |
| Total Compound Content | 5mg + 5mg, 10mg | 10mg + 10mg, 20mg |
| Shelf Life | 36 months |
This blend vial contains BPC-157 (C62H98N16O22) and TB-500 (C212H350N56O78S) in a single lyophilized preparation. The two peptides exhibit distinct molecular mechanisms and signaling characteristics. BPC-157 has been investigated for interactions with VEGFR2-, ERK1/2-, eNOS-, and FAK-associated signaling networks together with regulatory processes involving extracellular protein systems. TB-500, a synthetic analogue of Thymosin Beta-4, regulates actin-associated processes through G-actin binding via the conserved LKKTET motif, influencing cytoskeletal organization, actin polymerization dynamics, and associated signaling pathways. Experimental investigations have examined both compounds across a range of peptide-mediated regulatory systems and molecular signaling networks. The co-formulated blend provides a single preparation for researchers investigating comparative or concurrent peptide-signaling mechanisms while reducing reconstitution complexity in multi-peptide study designs. Each peptide retains its individual chemical identity and pharmacological profile within the blend. Independently third-party HPLC-tested; COA available per batch.
BPC-157 5mg + TB-500 5mg Blend (Endotoxin)
June 17, 2026 · Janoshik
BPC-157 5mg + TB-500 5mg Blend (LC-MS)
June 17, 2026 · Janoshik
BPC-157 5mg + TB-500 5mg Blend (HPLC)
June 16, 2026 · Janoshik
BPC-157 5mg + TB-500 5mg Blend (Heavy Metal)
June 16, 2026 · Janoshik
BPC-157 5mg + TB-500 5mg Blend (HPLC)
June 16, 2026 · Janoshik
BPC-157 5mg + TB-500 5mg Blend (Heavy Metal)
June 16, 2026 · Janoshik
Do BPC-157 and TB-500 interact with the same signaling pathways, or do they exhibit distinct mechanisms?
BPC-157 and TB-500 exhibit distinct molecular mechanisms and signaling characteristics. BPC-157 has been investigated for interactions with VEGFR2-, ERK1/2-, eNOS-, and FAK-associated signaling networks together with regulatory processes involving extracellular protein systems. TB-500 interacts with G-actin through the conserved LKKTET motif, influencing actin polymerization dynamics, cytoskeletal organization, and actin-associated signaling pathways. While both peptides participate in broad regulatory signaling networks, their primary molecular targets and mechanisms remain distinct, making the blend useful for comparative investigation of multiple peptide-mediated pathways.
Is the purity and identity of each peptide maintained within the blend?
Yes. BPC-157 and TB-500 remain chemically distinct components within the lyophilized preparation and do not form covalent conjugates under standard manufacturing and storage conditions. Each peptide retains its individual amino acid sequence, molecular identity, physicochemical properties, and analytical profile. Independent third-party testing is performed to verify purity and quality specifications for the blend.
What distinguishes the blend formulation from individual peptide preparations?
The blend formulation combines BPC-157 and TB-500 within a single preparation while preserving the individual characteristics of each peptide. This format provides a convenient research tool for investigations involving comparative peptide pharmacology, concurrent evaluation of multiple signaling mechanisms, and studies examining interactions between distinct peptide-associated regulatory pathways. Researchers requiring separate experimental assessment of each peptide may alternatively utilize the individual preparations.
